| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.12. | Spritzer Bhd: Spritzer Clinches 10th Consecutive "Brand of the Year" Award at the World Branding Awards in London | 260 | JCN Newswire | The decade milestone achievement reinforces Spritzer's deep resonance with its customers, unwavering dedication to excellence in product qualityLONDON, Dec 3, 2024 - (ACN Newswire) - Spritzer has once... ► Artikel lesen | |
| 04.12. | Naoris Protocol announces World's First Post-Quantum DePIN for Cybersecurity & Digital Trust ahead of Testnet | 429 | JCN Newswire | Delaware, USA, Dec 4, 2024 - (ACN Newswire) - As the digital world is increasingly threatened by advanced cyberattacks and looming quantum computing challenges,Naoris Protocol unveils groundbreaking... ► Artikel lesen | |
| 04.12. | HKTDC: 25th Hong Kong Forum concludes successfully | 303 | JCN Newswire | - More than 320 leaders from Hong Kong Business Association Worldwide join - to explore the latest development opportunities in Hong KongHONG KONG, Dec 4, 2024 - (ACN Newswire) - The 25th Hong Kong... ► Artikel lesen | |
| 04.12. | CITIC Telecom CPC's Internal and External Cybersecurity Excellence Honored with 3 Industry Awards | 281 | JCN Newswire | - Fosters Cybersecurity Culture Among Staff and Network Security as Top Priority- Strengthens Ecosystem Collaboration and Empowers Enterprises to Combat Security ThreatsHONG KONG, Dec 4, 2024 - (ACN... ► Artikel lesen | |
| 04.12. | Denso: DENSO Signs Memorandum of Understanding with Canatu of Finland for Practical Application of Carbon Nanotube Technology | 548 | JCN Newswire | KARIYA, JAPAN, Dec 4, 2024 - (JCN Newswire) - DENSO Corporation has recently signed a Memorandum of Understanding (MOU) with Canatu to advance the practical application of carbon nanotube technology.... ► Artikel lesen | |
| 04.12. | Everest Medicines Limited: Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy | 282 | JCN Newswire | SHANGHAI, Dec 4, 2024 - (ACN Newswire) - - Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NOVO NORDISK | 1.588 |
| NVIDIA | 1.256 |
| TUI | 1.096 |
| TESLA | 1.071 |
| EVOTEC | 1.008 |
| BAYER | 998 |
| VOLKSWAGEN | 789 |
| NEL | 642 |
| D-WAVE QUANTUM | 618 |
| MICROSTRATEGY | 617 |
| SUPER MICRO COMPUTER | 604 |
| BYD | 600 |
| PALANTIR TECHNOLOGIES | 569 |
| RHEINMETALL | 529 |
| AIXTRON SE | 485 |
| RWE | 407 |
| PLUG POWER | 404 |
| RENK GROUP | 378 |
| BASF | 373 |
| MANZ | 365 |
| DEFI TECHNOLOGIES | 348 |
| ATOS | 340 |
| COMMERZBANK | 339 |
| MICRON TECHNOLOGY | 330 |
| AMD | 317 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
